Novartis Investigative Site

Toyonaka, Osaka 561-0871

0 studies enrolling now · 3 studies all time

What they study most

Asthma, Cardiovascular Disease, Pulmonary Disease, Chronic Obstructive, Type 2 Diabetes Mellitus

Studies at this site

• Dose-range Finding Efficacy and Safety Study for QBW251 in COPD Patients — Completed
• A Multicenter Randomized 52 Week Treatment Double-blind, Triple Dummy Parallel Group Study to Assess the Efficacy and Safety of QMF149 Compared to Mometasone Furoate in Participants With Asthma — Completed
• Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases) — Stopped early